Statistics
Publications
4
Citations
295
H-Index
4
Active since
2015
Steve T. Luk is an author at University of Hong Kong specializing in molecular oncology, oncology, and hepatocellular carcinoma.
Publications per year
2015–2021
4
4
Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
Man Tong, Noélia Che, Lei Zhou et al. · Journal of Hepatology · 2018 · 130 citations
Medicine, Oncology, Pharmacology +12
Steve T. Luk, Kai‐Yu Ng, Lei Zhou et al. · Hepatology · 2019 · 25 citations
1–4 of 4